Opiant Pharmaceuticals, Inc. - stock earnings
Stock symbol OPNT is outdated, potentially delisted? Maybe it is available on other exchange?
OPNT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | -9.9 million USD | 173874 USD |
| 2022Q2 | -11.7 million USD | 3.9 million USD |
| 2022Q1 | -12.2 million USD | 4.5 million USD |
| 2021Q4 | 752330 USD | 13.8 million USD |
| 2021Q3 | 3.4 million USD | 16.3 million USD |
| 2021Q2 | 1.7 million USD | 11.3 million USD |
| 2021Q1 | -2.8 million USD | 6.4 million USD |
| 2020Q4 | -685575 USD | 9.9 million USD |
OPNT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | 3.0 million USD | 47.8 million USD |
| 2020 | -1.9 million USD | 29.6 million USD |
| 2019 | 11.6 million USD | 40.5 million USD |
| 2018 | -21.2 million USD | 14.0 million USD |
| 2017 | 3.3 million USD | 28.2 million USD |
OPNT
Price: $20.65
52 week price:
Earnings Per Share: -3.33 USD
P/E Ratio: 34.80
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 65800
Ebitda: -5.6 millionMarket Capitalization: 108.8 million